글로벌 헤모글로빈 테스트 시장 – 2028년까지의 산업 동향 및 예측

헤모글로빈 테스트 시장의 시장 분석 및 통찰력

헤모글로빈 검사 시장은 2021년부터 2028년까지의 예측 기간 동안 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 위에 언급된 예측 기간 동안 시장이 9.18%의 CAGR로 성장할 것으로 분석합니다.

헤모글로빈 검사는 환자의 혈액에서 헤모글로빈 수치를 감지하기 위한 진단 검사를 실시하는 절차입니다. 헤모글로빈 검사는 의사가 정기 검진의 일부로 또는 환자의 심각한 의학적 상태를 분석하는 데 널리 사용됩니다.

다양한 건강 보험 정책에 따른 헤모글로빈 검사의 유리한 보상은 헤모글로빈 검사 시장의 성장과 수요를 강화할 것으로 예상되는 중요한 요인 중 하나입니다. 또한 빈혈 및 지중해 빈혈 환자 사이에서 가정 치료 선호도가 증가하고 다양한 시장 참여자가 핸드헬드 및 진료소 헤모글로빈 분석기 개발에 집중하는 것도 2021년에서 2028년까지의 예측 기간 동안 글로벌 시장 성장에 기여할 것으로 예상됩니다. 또한 전 세계적으로 당뇨병 인구의 유병률이 빠르게 증가하고 가정 기반 진단 검사의 발생률이 증가함에 따라 시장 성장이 촉진될 가능성이 높습니다. 나아가 건강 인프라가 개선되고 1인당 의료비 지출이 증가하는 것도 헤모글로빈 검사 시장 성장을 촉진할 것으로 예상되는 중요한 요인 중 하나입니다.                                                                                                                          

의료비 지출 의 증가 , 혈액 관련 질환에 대한 인식 제고, 빠른 결과와 사용 편의성을 제공하는 첨단 기술의 급속한 개발은 2021년에서 2028년까지의 예측 기간 동안 시장에 상당한 성장 기회를 제공할 것으로 예상됩니다.

However, the increase in the levels of costs associated with the medical devices and rise in the concerns regarding the high maintenance costs are expected to curb the growth of the hemoglobin testing market, whereas the lack of detection of other molecular components other than hemoglobin levels with this test can challenge the growth of the hemoglobin testing market.

This hemoglobin testing market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the hemoglobin testing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Hemoglobin Testing Market Scope and Market Size

The hemoglobin testing market is segmented on the basis of product type, technology and end user. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of product type, the hemoglobin testing market is segmented into automated hematology analyzers, point-of-care and reagents and consumables. Point-of-care has further been segmented into manual and digital.
• Based on technology, the hemoglobin testing market is segmented into chromatography, immunoassay and others.
• The end user segment of hemoglobin testing market is segmented into hospitals, research centers, laboratories, diagnostic centers, homecare settings and others.

 Hemoglobin Testing Market Country Level Analysis

The hemoglobin testing market is analyzed and market size insights and trends are provided by country, product type, technology and end user as referenced above.

The countries covered in the hemoglobin testing market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa(MEA), Brazil, Argentina and Rest of South America as part of South America.

North America region leads the hemoglobin testing market owing to the rise in the prevalence of thalassemia and other chronic blood disorders along with the increase in the number of diagnostic centers for the detection of hemoglobin levels and diagnosis of various hemoglobinopathies. Asia-Pacific is expected to expand at a significant growth rate over the forecast period of 2021 to 2028 because of the unmet medical needs and increase in the prevalence and incidence of diabetes.

The country section of the hemoglobin testing market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

The hemoglobin testing market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for hemoglobin testing market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the hemoglobin testing market. The data is available for historic period 2010 to 2019.

Competitive Landscape and Hemoglobin Testing Market Share Analysis

The hemoglobin testing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to hemoglobin testing market.

헤모글로빈 검사 시장 보고서에 포함된 주요 기업으로는 Abbott, Bio-Rad Laboratories, Inc., Danaher, F. Hoffmann-La Roche Ltd, EKF Diagnostics, Siemens Healthcare GmbH, Thermo Fisher Scientific Inc., ACON Laboratories, Inc., BIOMEDOMICS INC., Hemosure, Inc., Humasis Co., Ltd., Immunostics Inc., Germaine Laboratories, Inc., Portea Medical, LifeSign LLC, Medix Biochemica, Nanoentek, Quidel Corporation, TCS Biosciences Ltd., Nova Biomedical 등이 있으며, 국내 및 글로벌 기업도 있습니다. 시장 점유율 데이터는 글로벌, 북미, 유럽, 아시아 태평양(APAC), 중동 및 아프리카(MEA), 남미에 대해 각각 제공됩니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁자에 대한 경쟁 분석을 개별적으로 제공합니다.

SKU-44746